Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.97
-0.0999-3.25%
Last update: Feb 17, 11:44 AM
Comments
Loading...
Dogwood Therapeutics Inc Analyst Ratings
DWTXNASDAQ
Dogwood Therapeutics Analyst Ratings and Price Targets | NASDAQ:DWTX | Benzinga
Dogwood Therapeutics Inc has a consensus price target of $12 based on the ratings of 1 analysts. The high is $12 issued by HC Wainwright & Co. on January 30, 2026. The low is $12 issued by HC Wainwright & Co. on January 30, 2026. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on January 30, 2026, September 30, 2025, and April 23, 2025, respectively. With an average price target of $11.33 between HC Wainwright & Co., there's an implied 281.58% upside for Dogwood Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Dogwood Therapeutics
FAQ
What is the target price for Dogwood Therapeutics (DWTX) stock?
The latest price target for Dogwood Therapeutics (NASDAQ:DWTX) was reported by HC Wainwright & Co. on January 30, 2026. The analyst firm set a price target for $12.00 expecting DWTX to rise to within 12 months (a possible 304.03% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dogwood Therapeutics (DWTX)?
The latest analyst rating for Dogwood Therapeutics (NASDAQ:DWTX) was provided by HC Wainwright & Co., and Dogwood Therapeutics reiterated their buy rating.
When was the last upgrade for Dogwood Therapeutics (DWTX)?
The last upgrade for Dogwood Therapeutics Inc happened on April 23, 2025 when HC Wainwright & Co. raised their price target to $10. HC Wainwright & Co. previously had a neutral for Dogwood Therapeutics Inc.
When was the last downgrade for Dogwood Therapeutics (DWTX)?
There is no last downgrade for Dogwood Therapeutics.
When is the next analyst rating going to be posted or updated for Dogwood Therapeutics (DWTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dogwood Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dogwood Therapeutics was filed on January 30, 2026 so you should expect the next rating to be made available sometime around January 30, 2027.
Is the Analyst Rating Dogwood Therapeutics (DWTX) correct?
While ratings are subjective and will change, the latest Dogwood Therapeutics (DWTX) rating was a reiterated with a price target of $12.00 to $12.00. The current price Dogwood Therapeutics (DWTX) is trading at is $2.97, which is out of the analyst’s predicted range.
